Better information --> better decisions --> better health1 ScotPHO Training Day Hospital Standardised Mortality Ratios Richard Dobbie Gavin MacColl (ISD.

Slides:



Advertisements
Similar presentations
Session 1: Responding to Unwarranted Clinical Variation: A Case Jean-Frederic Levesque Chief Executive, Bureau of Health Information.
Advertisements

COPD Analyses Updated – 7th February February 2011.
Epidemiology and benefit to patients from accurate coding Heather Walker CHKS Consultancy and Marketing Director 4 th May 2012.
Interpreting the Commissioning for Value Packs
Scottish Stroke Care Audit System NHS Fife 2012 data Dr Sue Pound, Stroke Consultant Hazel Fraser Stroke Co-ordinator Isla McBain, Stroke Audit assistant.
Line Efficiency     Percentage Month Today’s Date
Mary Day Chief Executive MMUH Patient Safety Conference 2014 MATER BOARD ON BOARD Quality Improvement Project.
Centre for Health Economics Modelling the impact of being obese on hospital costs Katharina Hauck Bruce Hollingsworth.
Your life in their hands Mortality as a measure of clinical performance David Prytherch, Jeff Sirl, Paul Weaver, Paul Meredith, Michael Booth.
West Hertfordshire Hospitals NHS Trust Analysing mortality data derived from Secondary User Services.
Notes  Data are presented as a pair of overlying bars, the outer, wider bar representing the period 1st Oct 2007 to 30th September 2008, and the inner,
1 25th ECCMID , Munich, Germany Magnitude of bacteremia predicts one-year mortality Kim O. Gradel 1, Henrik C. Schønheyder 1,2, Mette Søgaard 1,
Death and the Infirmary Standardised Mortality at Hull & East Yorkshire Hospitals NHS Trust.
Mortality measures 18 March 2008 Mike Davidge. Mortality measures What measure are we using? To track the progress of the campaign we are using Brian.
Surveillance of Heart Diseases and Stroke Using Centers for Medicare and Medicaid (CMS) Data: A Researcher’s Perspective Judith H. Lichtman, PhD MPH Associate.
SPARRA Peter Martin Programme Principal Long Term Conditions/Joint Future Programmes.
Sasha Karakusevic. We have achieved substantial improvements for our community and receive positive feedback from patients and the public Both the Care.
Scottish Health Information Service (SHIS) SCIMP, November 2007 Jill Telfer Penny Bridger.
Improving the quality of medical and surgical care 1 Subarachnoid Haemorrhage.
*Data from July-December 2013 is for GNEF CHP only. From January 2014 onwards this will also include Acute Services Division data. SAFEEFFECTIVE C difficile.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Acute Quality Standards Dan Beckett Acute Physician CMO Advisor for Acute & General Medicine.
EFFECTIVE C difficile (over 65) Oct-Dec 13 MRSA bacteraemia Oct-Dec 13 MSSA bacteraemia Oct-Dec 13 Activity was 82,314 patient episodes which included.
SOCIO-ECONOMIC STATUS AND MORTALITY FROM CARDIOVASCULAR DISEASE AMONG PEOPLE WITH TYPE 2 DIABETES IN SCOTLAND ( ) Caroline Jackson, Jeremy Walker,
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
Ryan Kelly Dr. Nicolas Shammas Christine Beuthin Jackie Carlson Marti Cox Kathy Lenaghan Dr. Ram Niwas Dr. Jon Lemke 06/18/15 ASSESSMENT OF TIME TO HOSPITAL.
Measuring trauma outcomes & processes of trauma care The Trauma Audit & Research Network (TARN) Data Collection session.
The EuroHOPE- project: Comparison of treatment and outcome for AMI and stroke patients in Europe On behalf of the EuroHOPE-team: Terje P. Hagen Department.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
Advancing Excellence in Health Care 2.0 ETA December 2010 Carol Sniegoski AHRQ Annual Conference September 27, 2010 Preview:
Scotland’s Approach to
Harnessing Clinical Terminologies and Classifications for Healthcare Improvement Janice Watson Terminology Services Manager 11 th April 2013.
Developments & Issues in the Production of the Summary Hospital-level Mortality Indicator (SHMI) Health and Social Care Information Centre (HSCIC)
EFFECTIVE C difficile (over 65) Apr-Jun 14 MRSA bacteraemia Apr-Jun 14 MSSA bacteraemia Apr-Jun 14 For the 2 month period Sep-Oct 2014, there were 10,413.
Northern Lincolnshire Healthy Lives Healthy Futures Programme NEL CCG Partnership Board Update September 2014.
Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.
Studying Health Care: Some ICD-10 Tools Hude Quan, Nicole Fehr, Leslie Roos University of Calgary and Manitoba Centre for Health Policy.
Presented By: Gwen Nuttall – Chief Operating Officer, Nichole Day Executive Chief Nurse Prepared By: Information Team Date Prepared: 15 th April 2011 Subject:
Probability of Survival (Ps) & Hospital Survival Rate (Ws) The Trauma Audit & Research Network (TARN)
EFFECTIVE C difficile (over 65) Jul-Sep 15 MRSA bacteraemia Jul-Sep 15 MSSA bacteraemia Jul-Sep 15 For the 2 month period Jan-Feb 2016, there were 10,813.
What data are collected? How, and who by? Karen Graham and Barry Plewa.
EC TWINNING PROJECT Development of National Coding Standards within the Czech DRG System CZ2005/IB/SO/03.
Baseline The baseline at July Previously there was a lack of consistency for: Pathways into specialist clinics; Policies, procedures and guidelines.
South West Public Health Observatory South West Regional Public Health Group Trends in End of Life Care in the South West Mark Dancox, Andy Pring, Roy.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.
Insert name of presentation on Master Slide Annual Quality Framework Quality & Safety improvement Reporting.
Probability of Survival (Ps) & Hospital Survival Rate (Ws) The Trauma Audit & Research Network (TARN)
Royal College of Physicians of Edinburgh Scottish Stroke Collaboration Meeting 22nd September 2010 Queen Mother Conference Centre.
Jan 2016 Solar Lunar Data.
Probability of Survival (Ps) & Hospital Survival Rate (Ws) The Trauma Audit & Research Network (TARN)
Lynn Josephs, David Culliford, Matthew Johnson, Mike Thomas
Mortality and harm reduction in Cwm Taf Health Board
HEART FAILURE TEAM MEMBERSHIP
2017 Jan Sun Mon Tue Wed Thu Fri Sat
Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
PCS Day - Feedback 23th November 2016, Vienna.
Jan Sun Mon Tue Wed Thu Fri Sat
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
TIMELINE NAME OF PROJECT Today 2016 Jan Feb Mar Apr May Jun
Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

better information --> better decisions --> better health1 ScotPHO Training Day Hospital Standardised Mortality Ratios Richard Dobbie Gavin MacColl (ISD Quality Improvement Programme)

Quality Improvement Programme Hospital Standardised Mortality Ratios (HSMR’s) Surgical / Medical Profiles Scottish Arthroplasty Project Complaints Incident Reporting Pilot ‘Better Together’ Inpatient Survey National Audits SICSAG / Stroke / STAG-Sepsis / Renal Registry Routine Linked Data Quality Strategy – Patient Centred Clinical Engagement

better information --> better decisions --> better health3 What is an HSMR? Observed Deaths Predicted Deaths HSMR =  Observed Deaths =Deaths  Predicted Deaths =Predicted Probabilities

better information --> better decisions --> better health4 Data source - SMR01/GRO linked data Outcome - 30 day mortality Patient indexing – Quarterly (CIS) Explanatory variables Age, sex, deprivation Type of admission (elective / non-elective) Inpatient / day case Place admitted from Number of previous emergency admissions Primary diagnosis Prior morbidity – 1 and 5 years Surgical / non-surgical specialty HSMR Methodology

better information --> better decisions --> better health5 Patient Record Sets HSMR’sSAPProfiles

better information --> better decisions --> better health6 Primary diagnosis group 30 day mortality ratePrimary diagnosis group 30 day mortality rate Cerebrovascular112.4 (8.3 – 13.8)Malignancy316.6 (14.7 – 30.3) Cerebrovascular224.3 (19.3 – 40.1)Metabolic3.2 (0.9 – 8.7) CVS12.3 (1.3 – 7.2)Miscellaneous11.0 (0 – 2.83) CVS211.0 (8.2 – 13.5)Miscellaneous25.6 (3.7 – 18.2) CVS315.9 (13.7 – 31.3)Mortality93.0 (92.9 – 100.0) CVS468.0 (62.5 – 70.8)Neurological11.1 (0.6 – 2.9) Gastrointestinal11.4 (0.7 – 4.1)Neurological24.5 (2.5 – 17.4) Gastrointestinal26.5 (5.0 – 15.7)Renal17.8 (8.3 – 22.2) Gastrointestinal313.4 (10.1 – 23.4)Respiratory12.5 (0.7 – 4.3) Haematology2.7 (1.5 – 6.1)Respiratory26.6 (3.2 – 9.0) Low risk0.2 (0 – 0.6)Respiratory326.1 (8.9 – 47.8) Malignancy13.9 (1.5 – 7.4)Trauma11.2 (0.7 – 3.0) Malignancy211.4 (8.1 – 14.2)Trauma26.3 (3.1 – 16.7) Primary Diagnostic Groupings

better information --> better decisions --> better health7 ConditionWeight (1=least severe, 6=most severe) Acute myocardial infarction1 Congestive heart failure1 Peripheral vascular disease1 Cerebral vascular accident1 Dementia1 Pulmonary disease1 Connective tissue disorder1 Peptic ulcer1 Liver disease1 Diabetes1 Diabetes complications2 Paraplegia2 Renal disease2 Cancer2 Metastatic cancer3 Severe liver disease3 HIV6 Prior Morbidity

better information --> better decisions --> better health8 Scottish Case-Mix Model (selected pathways in model)

better information --> better decisions --> better health9 Timeline of HSMR Development March 08 QIP starts development Surgical Profile May 08 Learning Session 2 Progress reported to senior NHS leaders Recommendation to establish design group Aligned to an extent with Dr Foster December 08 First Results Released Admissions: October 2006 to September 2007 Communication: SPSA to Chief Executives No outliers on the funnel plot January 09 Learning Session 3 Methods and results of validation presented

better information --> better decisions --> better health10 Timeline of HSMR Development May 09 Updated Analysis Admissions: October 2007 to September 2008 Data passed to the SPSA No data circulated to Chief Executives May 09 Learning Session 4 Sep – Dec 09 Model adapted for quarterly reporting November 09 Learning Session 5 Quarterly Model explained December 09 Quarterly HSMR’s Released Time series per hospital showing observed and expected deaths Communication: ISD Director to CEOs and MDs Password protected area on ISD Website

better information --> better decisions --> better health11 Quarterly Release

better information --> better decisions --> better health12 Quarterly Release

better information --> better decisions --> better health13 Quarterly Release Baseline

better information --> better decisions --> better health14 Jul – Sep 10Oct – Dec 10Jan – Mar 11Apr – Jun 11 4 Months3 Months Jan – Mar 09Apr – Jun 09Jul – Sep 09Oct – Dec 09 9 Months Addressing Timeliness

better information --> better decisions --> better health15 Timetable DatePre-release Access to Boards or into Public Domain Reporting Final Data to:Provisional Results Tues. 27 th Jul 2010Pre-release31 st Dec 2009N/A Tues. 31 st Aug 2010Public31 st Dec 2009N/A Tues. 26 th Oct 2010Pre-release31 st Mar 2010Apr–Jun 2010 Tues. 30 th Nov 2010Public31 st Mar 2010Apr–Jun 2010 Tues. 25 th Jan 2011Pre-release30 th Jun 2010Jul-Sep 2010 Tues. 22 nd Feb 2011Public Release30 th Jun 2010Jul-Sep 2010 Tues. 26 th Apr 2011Pre-release30 th Sep 2010Oct-Dec 2010 Tues. 31 st May 2011Public Release30 th Sep 2010Oct-Dec 2010 Tues. 26 th Jul 2011Pre-release31 st Dec 2010Jan-March 2011 Tues. 30 th Aug 2011Public Release31 st Dec 2010Jan-March 2011 Tues. 25 th Oct 2011Pre-release31 st Mar 2011Apr–Jun 2011 Tues. 29 th Nov 2011Public Release31 st Mar 2011Apr–Jun 2011 Tues. 31 st Jan 2012Pre-release30 th Jun 2011Jul-Sep 2011 Tues. 28 th Feb 2012Public Release30 th Jun 2011Jul-Sep 2011 Tues. 24 th Apr 2012Pre-release30 th Sep 2011Oct-Dec 2011 Tues. 29 th May 2012Public Release30 th Sep 2011Oct-Dec 2011 Tues. 31 st Jul 2012Pre-release31 st Dec 2011Jan-March 2012 Tues. 28 th Aug 2012Public Release31 st Dec 2011Jan-March 2012

better information --> better decisions --> better health16

better information --> better decisions --> better health17 What is a High HSMR? A high HSMR where variation greater than +3SDs above Scotland HSMR –Also where HSMR >Scot HSMR but within control limits; Where HSMR is increasing or is steady over time Distribution of variation shown on a funnel plot In addition to published data, HSMR used as part of an internal process to highlight hospitals with exceptional variation (variation outwith norm) Data variability on a funnel plot is not published – risk of league tables Escalation protocol for potential quality/safety concerns flagged up by data – instigated by QIS (HIS) and ISD

better information --> better decisions --> better health18 HSMR Funnel Plot Scot HSMR Hospitals HSMR Control Limits Upper & Lower CL+2SD CL+3SD CL-2SD CL-3SD Unusual HSMR above CL(+3SD)

better information --> better decisions --> better health19 Information Support to Boards 1 Provide data to support further investigation into high HSMR HSMR trend over time and control limits

better information --> better decisions --> better health20 Information Support to Boards 2 HSMR within control limits over time Scot HSMR HSMR within Control limits

better information --> better decisions --> better health21 Information Support to Boards 2 HSMR reaching control limits Scot HSMR Unusual HSMR above CL(+3SD)

better information --> better decisions --> better health22 Information Support to Boards 2 Provide data to support further investigation into high HSMR HSMR trend over time and control limits HSMR stratified : Elective / non elective admissions, age group, specialty, diagnostic grouping

better information --> better decisions --> better health23 Information Support to Boards 2 Elective / non elective, age group, specialty, diagnostic grouping Example HSMR elective / non elective, age group, specialty, diagnostic grouping

better information --> better decisions --> better health24 Information Support to Boards 2 Scot HSMR HSMR Elective / non elective, age group, specialty, diagnostic grouping Indicator of where to start to look Indicate where Scot HSMR < lower 95% CI HSMR

better information --> better decisions --> better health25 Information Support to Boards 3 Case Listing Deaths 30-Day Survivors

better information --> better decisions --> better health26 Information Support to Boards 3 Case Listing Unlikeliest Death According to Model Unlikeliest Survivor According to Model

better information --> better decisions --> better health27 Information Support to Boards 3 Value of Case Listing Review of the patient journey Review of clinical records ICD 10 coding vs SMR01 linked file HSMR catalyst for improvement(s) in SMR01 coding accuracy

better information --> better decisions --> better health28 Three funnel plots Effect of Coding

better information --> better decisions --> better health29 Regression – Scotland, Crosshouse The 15% ‘Target’

better information --> better decisions --> better health30 Importance of Robust Clinical Coding –Individual probabilities of death based on ICD-10 coding Supporting Users –Developing data pack (case listings, aggregations etc) –Working (proactively with stakeholders locally to avoid surprises –Main contacts (Patient Safety Leads, Clinical Governance) –Refer to existing resources (Navigator, Surgical / Medical Profile, ACaDMe) Data Timeliness –SMR01 and GRO data submissions –30-day Follow-up –Reduced lag Issues

If you would like to contact us: Richard Dobbie Gavin MacColl Website address: Thank you very much for listening

better information --> better decisions --> better health32 Any Questions?